Drug abuse testing devices play a vital role in detecting the presence of drugs in an individual's system to determine if they are under the influence of alcohol or illegal substances. These devices not only help employers and healthcare professionals screen individuals for drugs but also aid in rehabilitation and reducing drug abuse.
The U.K. Drug For Abuse Testing Devices Market Size is estimated to be valued at US$ 367.68 Mn in 2024 and is expected to exhibit a CAGR of 1.8% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increased adoption of alcohol and drug screening devices in workplaces is one of the key trends propelling the growth of the U.K. drug abuse testing devices market. According to the Health and Safety Executive, in the U.K., an estimated 54,270 workers suffered from a non-fatal injury caused due to being under the influence of drugs or alcohol in 2018–2019. As a result, many companies have made drug testing mandatory, especially for jobs related to transportation, construction, oil and gas, and machinery operation. Various companies are launching innovative drug screening devices equipped with new technologies like immunoassay testing and chromatography testing that can detect multiple drugs simultaneously with high accuracy. This is expected to boost the demand for drug abuse testing devices over the forecast period.
Segment Analysis
The U.K. drug for abuse testing devices market is dominated by the consumables sub-segment. This is because consumables which include assay kits and reagents are required regularly as they get consumed soon after a single use. Assay kits and reagents are needed to perform each drug screening test and their demand grows in line with the increasing number of drugs of abuse screenings being conducted in the country.
Key Takeaways
The U.K. drug for abuse testing devices market is expected to witness high growth. The U.K. Drug for Abuse Testing Devices Market is estimated to be valued at US$ 367.68 Mn in 2024 and is expected to exhibit a CAGR of 1.8% over the forecast period 2024 to 2031.
Regional analysis:
The North region currently dominates the U.K. drugs for abuse testing devices market owing to the presence of major companies and hospitals conducting a large volume of drugs screening tests. However, the Midlands region is expected to register the fastest growth over the forecast period led by rising substance abuse and increased emphasis on workplace drug testing by companies in this region.
Key players:
Key players operating in the U.K. drug for abuse testing devices market are CF Industries Holdings Inc., Yara, Nutrien Ltd, OCI, and QATAR FERTILISER COMPANY.
The U.K. drug for abuse testing devices market is fragmented in nature with the presence of several and regional players. Market leaders are focused on expanding their product portfolios through mergers & acquisitions and new product launches. Miniaturization of devices and integrated diagnostic platforms are some of the new trends gaining popularity. However, budget constraints remain a key challenge for widespread adoption of advanced screening tests in the country.
Get More Insights Here: https://www.newswirestats.com/u-k-drug-for-abuse-testing-devices-market-demand-growth-and-regional-outlook-by-2030/
Related Reports: https://lotstoexpress.com/whispers-of-the-genomics-exploring-the-secrets-hidden-in-every-stand/
